Alzheimer’s disease in Down syndrome similar to autosomal dominant form
May 25, 2022
Age at onset and mortality for Alzheimer’s disease in people with Down syndrome were comparable with fully penetrant form of the disease.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
ENT-01 safe, improves constipation in patients with Parkinson’s disease
Nov 07, 2022
Improvement was seen in the weekly complete spontaneous bowel movement rate and in secondary end points
.
Donanemab slows clinical progression in early Alzheimer’s disease
Jul 17, 2023
The drug slows clinical progression at 76 weeks for those with low/medium tau and the combined low/medium and high tau pathology population.
Antihypertensive meds initiation linked to fractures in nursing home seniors
Apr 23, 2024
Antihypertensive medication initiation also was linked to a higher risk for severe falls requiring hospitalization and emergency department visits.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Improved air quality may slow cognitive decline in older women
Feb 09, 2022
No differences in associations were seen according to age, geographic region, education, apolipoprotein E e4 genotypes or cardiovascular risk factors.
17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
Questions remain about safety of aspirin cessation in older adults
Mar 14, 2022
The findings were inconclusive for a subgroup analysis looking at the safety of ceasing regular aspirin use without a clinical indication after age 70 years.
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.